Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Aditxt, Inc. develops and commercializes innovative health technologies through a collaborative ecosystem that integrates licensing, development, and commercialization. Its portfolio includes immune modulation therapies, precision health diagnostics, and mitochondrial DNA-based biomarker platforms targeting autoimmune diseases, cancer, and infectious diseases. The company partners with research institutions and healthcare providers to advance personalized and population health solutions, leveraging proprietary technologies and a systemized approach to transform promising innovations into scalable, market-ready products.
This description was generated via AI from an annual report. Updated about 1 year ago.